| Today's Open | $39.99 |
|---|---|
| Previous Close | $40.21 |
| Daily Range | $39.96 - $40.08 |
| 52-Week Range | $36.63 - $42.83 |
| Market Cap | $34.0B |
| P/E Ratio | 17.87 |
| Dividend (Yield) | $1.09 (2.4%) |
| Ex-Dividend Date Dividend Pay Date |
05/16/13 06/03/13 |
| Volume | 299,433 |
| Average Daily Volume | 3,883,016 |
| Current FY EPS | $5.05 |
Sector
Healthcare
Industry
Drugs
Teva Pharmaceutical Industries (TEVA) Description
A global pharmaceutical company, Teva develops, produces, and markets generic drugs covering all major treatment categories. Website: http://www.tevapharm.com/
News & Commentary
Does it really matter?
Multiple Sclerosis and Hemophilia: This Biotech's Just Getting Started
Biogen's MS drug is off to a hot start, and its new hemophilia drugs are under FDA review.Statin Users May Have a Reason to Rejoice After This Data
An American Society of Clinical Oncology abstract demonstrates a potentially positive long-term side effect of statin use.TEVA's Top Competitors
(-0.82%)
(1.12%)
(1.19%)
(2.34%)